SCHEMBL4328124

SCHEMBL4328124

COc1ccc2[nH]cc(/C=C3\Oc4ccc(Br)cc4C3=O)c2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.62
MTOR P42345 3/20 0.62
PIK3CG P48736 2/20 0.62
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
NTRK1 P04629 3/20 0.48
NTRK3 Q16288 2/20 0.48
NTRK2 Q16620 2/20 0.48
PRKD3 O94806 1/20 0.48
ABL1 P00519 1/20 0.48
RET P07949 1/20 0.48
PDGFRB P09619 1/20 0.48
LTK P29376 1/20 0.48
KDR P35968 1/20 0.48
MAP2K2 P36507 1/20 0.48
FLT3 P36888 1/20 0.48
CSNK1A1 P48729 1/20 0.48
CDK8 P49336 1/20 0.48
CDK7 P50613 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1428916 1.00 PIK3CA (0.62) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL4325330 0.86 PIK3CA (0.67) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL4325326 0.86 PIK3CA (0.67) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL1429666 0.85 PIK3CA (0.59) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL4315849 0.85 PIK3CA (0.59) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL4322414 0.84 PIK3CA (0.71) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL1429464 0.84 PIK3CA (0.71) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL4314988 0.83 PIK3CA (0.73) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL4314992 0.83 PIK3CA (0.73) PIK3CAMTORPIK3CGALDH1A1CYP1A2
SCHEMBL1428699 0.82 PIK3CA (0.77) PIK3CAMTORPIK3CGALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US claimed
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES WYETH (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090311217-A1 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES MTOR, RICTOR, PDPK1 PIK3CA 4/4885MTOR 1/4885PIK3CG 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.